ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 41328708

Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes.

Thomas N and 8 others. Diabetes Metab Res Rev, 2026. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes. Papers, record 41328708. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41328708

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes.
PubMed
Journal
Diabetes Metab Res Rev
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-25
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thomas NNick
2Vaidya BBijay
3Leslie RDRichard Davidhttps://orcid.org/0000-0002-1786-1531
4Agardh DDaniel
5Oram RRichard
6Dabelea DDana
7Singh AArunjot
8Chantzichristos DDimitrios
9Rewers MMarian

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 1Major topic
Autoimmune DiseasesMajor topic
Humans
Autoantibodies
Risk Factors

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DK032493NIDDK NIH HHSUnited StatesR01DK032493PubMedNIH RePORTER
SanofiPubMedPubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References99

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120,056,952Age at development of type 1 diabetes- and celiac disease-associated antibodies and clinical disease in genetically susceptible children observed from birth.Diabetes Care2010https://conductscience.org/library/papers/20056952PubMed
230,471,182Identification of autoimmune type 1 diabetes and multiple organ-specific autoantibodies in adult-onset non-insulin-requiring diabetes in China: A population-based multicentre nationwide survey.Diabetes Obes Metab2019https://conductscience.org/library/papers/30471182PubMed
311,988,243Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study.Lancet2002https://conductscience.org/library/papers/11988243PubMed
437,231,274The countdown to type 1 diabetes: when, how and why does the clock start?Diabetologia2023https://conductscience.org/library/papers/37231274PubMed
519,543,881Familial association between type 1 diabetes and other autoimmune and related diseases.Diabetologia2009https://conductscience.org/library/papers/19543881PubMed
612,357,294Family history and risk of type 1 diabetes mellitus.Acta Diabetol2002https://conductscience.org/library/papers/12357294PubMed
733,029,656Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells.Diabetologia2020https://conductscience.org/library/papers/33029656PubMed
823,780,460Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.JAMA2013https://conductscience.org/library/papers/23780460PubMed
925,849,566Global epidemiology of type 1 diabetes in young adults and adults: a systematic review.BMC Public Health2015https://conductscience.org/library/papers/25849566PubMed
1015,699,507No evidence of pancreatic autoimmunity among patients with multiple sclerosis.Ann N Y Acad Sci2004https://conductscience.org/library/papers/15699507PubMed

1 to 10 of 99

See all 99 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42,424,245Screening and Monitoring for Presymptomatic Type 1 Diabetes: A Time for Action.Horm Res Paediatr2026https://conductscience.org/library/papers/42424245PubMed
41,328,708Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes.Diabetes Metab Res Rev2026https://conductscience.org/library/papers/41328708PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41328708

GET https://conductscience.org/api/papers/v1/41328708/references?page=2

API referenceFor AI assistants